Drug Discovery World

JULY 14, 2023

International investors are abandoning UK life sciences as excessive revenue clawback rates start to bite, according to the latest Life Sciences Competitiveness Indicators published by the government 1. While this drop is in part due to the pandemic related spike in life sciences investment in 2020 and 2021, the £7.1

Life Science 52

Life Science Branding Manufacturing Medicine 52

Drug Discovery World

DECEMBER 4, 2023

It is hope that the new centre, which is due for completion in summer 2025, will set the stage for a thriving life sciences cluster in the area. It will be home to commercial businesses as well as the University of Glasgow-led Living Laboratory for Precision Medicine.

Life Science 52

Life Science Medicine Drugs Research 52

Drug Discovery World

MARCH 16, 2023

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? Regulation for medicines There were significant changes announced regarding the UK’s medicines regulator, the Medicines and Healthcare Regulatory Agency (MHRA).

Life Science 97

Life Science Regulation Medicine Research 97

XTalks

MAY 15, 2024

Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurological disorders. Dr. Levin has practiced medicine at university hospitals in England, South Africa and Switzerland. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 69

Life Science Medicine Clinical Research Development 69

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

MAY 9, 2024

A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on effect on the entire life sciences industry.

Life Science 104

Life Science Drugs Medicine Development 104

Drug Discovery World

JULY 4, 2023

Vesalius Biocapital, a life sciences venture capital investor, has closed its fourth fund, Vesalius Biocapital IV, securing over €95 million of commitments. The company plans to invest in first and best-in-class European life science companies in drug development and digital health.

Life Science 52

Life Science Sales Development Medicine 52

XTalks

JANUARY 10, 2024

Dr. Kaplin transitioned into industry by joining MIRA Pharmaceuticals to help lead drug development in the space. He also served as Co-Founder of numerous healthcare related startups, including, from 2018 to present, REWARD Pathways, a company devoted to addiction treatment focused on a combined eHealth and medicine approach.

Life Science 52

Life Science Development Drugs Medicine 52

XTalks

AUGUST 23, 2023

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Williams about BriaCell’s novel cell therapies for cancer and what the future of immunotherapy and personalized treatments may look like.

Life Science 98

Life Science Clinical Trials Clinical Trials FDA Approval 98

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? Our products are used primarily in the fight against cancer – to aid drug discovery – while also ensuring patients and laboratory workers are safe. I was encouraged instead to use my interest in science and study medicine, and I trained to be a hospital doctor at King’s College London.

Life Science 96

Life Science Engineer Scientist Doctors 96

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

XTalks

NOVEMBER 15, 2023

The drug was approved by the FDA last year for the treatment of ALS. There are currently no approved medicines to treat PSP. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The ORION study will evaluate the safety, efficacy and tolerability of AMX0035 in PSP patients.

Life Science 52

Life Science Trials Clinical Trials Clinical Trials 52

Pharmaceutical Technology

JULY 1, 2022

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. Ayvakit has received the US Food and Drug Administration (FDA) approval to treat advanced systemic mastocytosis in adults.

Medicine 147

Medicine Business Development Sales Life Science 147

XTalks

OCTOBER 25, 2023

Genevieve Neal-Perry, MD, PhD, professor and chair at the UNC School of Medicine Department of Obstetrics and Gynecology, and lead investigator on a study investigating Astellas Pharma’s fezolinetant (Veozah), which received FDA approval in May this year for the treatment of moderate to severe vasomotor symptoms due to menopause.

Life Science 52

Life Science Trials FDA Approval Hormones 52

XTalks

MAY 3, 2023

In this episode, Vera talked about how a couple of direct-to-consumer TV commercials have helped a medical device company, Axonics, establish its reputation in the non-drug incontinence therapy space. The team discussed Axonics Therapy and the occurrence of non-drug (medical device) TV ads.

Life Science 52

Life Science Drugs Medicine 52

XTalks

JUNE 14, 2023

This episode features an interview with Dr. Courtney Silverthorn who is an Associate Vice President at the Foundation for the National Institutes of Health (FNIH) and the Director of the Accelerating Medicines Partnership (AMP) program including the Bespoke Gene Therapy Consortium.

Gene Therapy 98

Gene Therapy Life Science Gene Clinical Trials 98

pharmaphorum

JULY 19, 2021

A new report published by Medicines Discovery Catapult and CPI details the huge medical and market potential for complex medicines in the UK. A complex medicine applies novel technologies that deliver or target drugs, by modification of a pharmaceutical ingredient, formulation or using a new delivery route.

Life Science 52

Life Science Medicine RNA Vaccination 52

XTalks

MARCH 30, 2022

The editorial team discussed the increasing frequency of recalls of commonly prescribed drugs like blood pressure and diabetes medications. Should companies and regulators share more information about the steps being taken to address the issue of drug impurities?

Life Science 93

Life Science Manufacturing FDA Approval Drugs 93

XTalks

AUGUST 2, 2023

Lawrence Eichenfield, chief of pediatric and adolescent dermatology at Rady Children’s Hospital-San Diego, and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Eichenfield.

Life Science 52

Life Science FDA Approval Dermatology Pharmacy 52

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Remote-controlled robotic labs.

Development 311

Development Drugs Pharma Companies Life Science 311

XTalks

MARCH 1, 2023

In this week’s Xtalks Life Science podcast episode, Sarah spoke with Doug Biehn, Chief Commercial Officer at Cala Health , a bioelectronic medicine company that develops wearable neuromodulation therapies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Medicine Production Development 52

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 117

Medicine Life Science Marketing Clinical Trials 117

pharmaphorum

SEPTEMBER 30, 2020

This is a key theme of the EU recovery plan but also the EU4Health and expected new “Pharmaceutical Strategy” that will “aim to ensure Europe’s supply of safe and affordable medicines to meet patients’ needs and support the European pharmaceutical industry to remain an innovator and world leader”. This makes a lot of sense.

Life Science 141

Life Science Medicine Trials Marketing 141

BioTech 365

OCTOBER 1, 2021

Global Psychedelic Drugs Market Review and Outlook, 2021 | Featuring Profiles of Jazz Pharma, PharmaTher Holdings, ATAI LIFE SCIENCES, COMPASS Pathways, Mind Medicine, and Janssen Pharma – ResearchAndMarkets.com Global Psychedelic Drugs Market Review and Outlook, 2021 | Featuring Profiles of … Continue reading →

Life Science 40

Life Science Medicine Marketing Drugs 40

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

pharmaphorum

NOVEMBER 7, 2022

“Jill is a wonderful addition to our executive team as we work to establish Lineage as a leader in cell therapy and cell transplant medicine,” stated Brian M Culley, Lineage CEO. ” The post The ins and outs of the life sciences: top hires for October 2022 appeared first on.

Life Science 102

Life Science Genetics Business Development Marketing 102

XTalks

MARCH 29, 2023

As new drug development is increasingly focused on targeted therapies for rare diseases and other indications with limited patient pools, healthcare commercial intelligence can help companies find their target market and help direct resources. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Gene Therapy Gene Medicine 52

XTalks

OCTOBER 11, 2023

The company was recently granted clinical trial authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its investigational biologic CAR T-Cell engager ALETA-001. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Clinical Trials Clinical Trials Scientist 52

Pharmaceutical Technology

MARCH 2, 2023

The growth in sales was driven by all regions and business sectors, particularly Life Science. to €10.38bn in its Life Science business during the year. The EBITDA pre of Life Science grew by 14.4% The increase in sales was due to new medicines. to €22.23bn in fiscal 2022 against €19.68bn in 2021.

Sales 245

Sales Life Science Licensing Licensing 245

XTalks

DECEMBER 12, 2023

Plasma medicine is a critical and specialized field within healthcare, centering on the use of human plasma for the development and administration of life-saving treatments. When people think about innovation drivers in global healthcare, they often think of “big pharma,” and not necessarily companies in the plasma medicines space.

Medicine 111

Medicine Recombinant Antibody Protein Antibody 111

STAT News

MARCH 9, 2023

FDA Commissioner Robert Califf joins to discuss his first year on the job, the future of drug approvals, and how Duke basketball will do without Coach K. Then STAT’s Elaine Chen explains how powerful new weight loss medicines are reshaping medicine, the drug industry, and the society at large.

Life Science 98

Life Science Drugs Medicine 98

XTalks

MAY 18, 2023

Woollett clears up some common misconceptions about achieving interchangeable status and addresses the issues with differences in global regulatory standards for biologics medicines. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Marketing Development Medicine 52

XTalks

JUNE 15, 2022

The drug was recently approved (under the brand name Mounjaro) by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes. The editorial team also discussed a new global biosimilars awareness campaign launched by Sandoz, Novartis’ biosimilars and generics drug division.

Life Science 52

Life Science Generic Drugs Branding Drugs 52

Drug Discovery World

FEBRUARY 24, 2023

Abbey Vangeloff is the Director of Business Development, Life Sciences, at Yahara Software. DDW’s Megan Thomas catches up with Vangeloff to learn why AI and data science are so important for the future of the sector. This, Vangeloff says, is the part they get excited about when working with life science clients.

Life Science 52

Life Science Drugs Bioinformatics Development 52

XTalks

JANUARY 5, 2021

Both drug discovery and drug repurposing to manage and treat the disease will also continue as experts learn more about the virology and epidemiology of the novel SARS-CoV-2 coronavirus that wreaked havoc in 2020. These include monoclonal antibody drugs, which are attractive therapeutic agents owing to their targeted specificity.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

Pharmaceutical Technology

MAY 22, 2023

Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore. The new good manufacturing practices facility was established with support from the Singapore Economic Development Board.

Genetic Analysis 147

Genetic Analysis Manufacturing Drugs Vaccination 147

The Pharma Data

MARCH 15, 2022

For the Sarclisa ® subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections , Inc. We are committed to build ing an industry-leading, sustainable pipeline with a steady stream of new therapies that have the potential to transform the practice of medicine ”. In the U.S.,

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52